These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 22437744)
1. Aggressive gastrointestinal stromal tumour of the oesophagus with homozygous KIT exon 11 deletion mutation. Cho J; Kang GH; Kim KM; Park J; Shim YM Pathology; 2012 Apr; 44(3):260-1. PubMed ID: 22437744 [No Abstract] [Full Text] [Related]
2. [Study on the mechanism of imatinib-induced resistance in gastrointestinal stromal tumors]. Zhou Y; Hou YY; Tan YS; Lu SH; Hou J; Liu JL; Qin J; Shen KT; Sun YH Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):597-601. PubMed ID: 20021947 [TBL] [Abstract][Full Text] [Related]
3. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones. Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259 [No Abstract] [Full Text] [Related]
4. A sporadic multiple gastrointestinal stromal tumor with unique clinical and molecular features. Pera M; Iglesias M; Puig S; Martínez-Avilés L; Bellosillo B Hum Pathol; 2011 Aug; 42(8):1194-9. PubMed ID: 21295327 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumor presenting as a rectovaginal mass. Clinicopathologic and molecular-genetic characterization of a rare tumor with a literature review. Pelz AF; Agaimy A; Daniels M; Evert M; Schulz HU; Lüders P; Müller G; Lasota J; Röpke A; Wieacker P; Miettinen M; Schneider-Stock R Hum Pathol; 2011 Apr; 42(4):586-93. PubMed ID: 21237497 [TBL] [Abstract][Full Text] [Related]
6. Optimizing diagnosis, staging, and management of gastrointestinal stromal tumors. Gutierrez JC; De Oliveira LO; Perez EA; Rocha-Lima C; Livingstone AS; Koniaris LG J Am Coll Surg; 2007 Sep; 205(3):479-91 (Quiz 524). PubMed ID: 17765165 [No Abstract] [Full Text] [Related]
7. Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation. Kobayashi M; Kuroki S; Ito K; Yasuda A; Sawada H; Ono K; Washizu T; Bonkobara M Vet J; 2013 Oct; 198(1):271-4. PubMed ID: 23820134 [TBL] [Abstract][Full Text] [Related]
8. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment. Yeh CN; Chen TW; Tseng JH; Liu YY; Wang SY; Tsai CY; Chiang KC; Hwang TL; Jan YY; Chen MF J Surg Oncol; 2010 Nov; 102(6):599-603. PubMed ID: 20976730 [TBL] [Abstract][Full Text] [Related]
9. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors. Miselli FC; Casieri P; Negri T; Orsenigo M; Lagonigro MS; Gronchi A; Fiore M; Casali PG; Bertulli R; Carbone A; Pierotti MA; Tamborini E; Pilotti S Clin Cancer Res; 2007 Apr; 13(8):2369-77. PubMed ID: 17438095 [TBL] [Abstract][Full Text] [Related]
10. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320 [TBL] [Abstract][Full Text] [Related]
11. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495 [TBL] [Abstract][Full Text] [Related]
12. Current management of GIST. Blanke C Clin Adv Hematol Oncol; 2004 May; 2(5):280, 283. PubMed ID: 17682286 [No Abstract] [Full Text] [Related]
13. Soft-tissue sarcomas in adults. Clark MA; Fisher C; Judson I; Thomas JM N Engl J Med; 2005 Aug; 353(7):701-11. PubMed ID: 16107623 [No Abstract] [Full Text] [Related]
14. Gastrointestinal stromal tumors (GISTs): a pathology view point. Sornmayura P J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254 [TBL] [Abstract][Full Text] [Related]
15. Resected duodenal gastrointestinal stromal tumour with an affected margin and exon 9 mutation: adjuvant therapy. Salas NR; Cubillo A Anticancer Drugs; 2012 Jun; 23 Suppl():S18-21. PubMed ID: 22713591 [TBL] [Abstract][Full Text] [Related]
16. Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach. Harrison ML; Goldstein D Intern Med J; 2006 Jun; 36(6):367-77. PubMed ID: 16732863 [TBL] [Abstract][Full Text] [Related]
18. Effect of imatinib mesylate in a patient with a metastatic gastrointestinal stromal tumor with a c-kit mutation in exon 11. Kubota K; Katayama A; Takeshita Y; Nozaki K; Ueda T; Imamura K; Hiki N; Nomura S; Kaminishi M; Mafune K Dig Dis Sci; 2007 Jul; 52(7):1725-9. PubMed ID: 17546507 [No Abstract] [Full Text] [Related]
19. [Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors]. Wardelmann E; Merkelbach-Bruse S; Büttner R; Schildhaus HU Verh Dtsch Ges Pathol; 2007; 91():165-8. PubMed ID: 18314611 [TBL] [Abstract][Full Text] [Related]
20. [Effect of c-kit mutation on the prognosis of gastrointestinal stromal tumors: a meta-analysis]. Zhao WY; Cao H; Zhang Y; Shen ZY; Wu ZY Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):857-62. PubMed ID: 19961019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]